Navigation Links
Genomic Vision Extends its Patent Portfolio With the Genomic Morse Code
Date:7/3/2012

PARIS, July 3, 2012 /PRNewswire/ --

Genomic Vision, a leading biotechnology company specializing in developing genetic diagnostic tests using DNA molecular combing, is announcing the extension of its intellectual property portfolio, with the granting in several countries of a patent on an innovative method of structural and visual analysis of the genome, called Genomic Morse Code (GMC).

     (Photo: http://photos.prnewswire.com/prnh/20120702/542983 )

"This new patent is in line with a solid portfolio of patents covering molecular combing, for which Genomic Vision holds the exclusive world license. With the GMC patent, the first of its own patents, Genomic Vision is strengthening its competitive edge and demonstrating its innovative force," says Aaron Bensimon, CEO of Genomic Vision.

The molecular combing technology allows direct microscopic visualization of large genomic regions using fluorescent markers. They form patterns specific to genomic locations using a limited number of colors, a little like traditional Morse Code, hence the name Genomic Morse Code.

Example of the gene for the genetic predisposition to cancer BRCA1. Image acquisition and analysis remain sufficiently simple thanks to the limited number of colors. Since pattern recognition is based on the size, spacing and color of several markers, the combinations are infinite, allowing for the coverage of any number of genes. Rearrangements are readily identified as modifications in the expected pattern. Photo credit: Genomic Vision©.

High-resolution technology on single DNA molecules

Genomic Morse Code is the key to diagnostics applications that make use of this high resolution, single DNA molecule technology.

"Genomic Vision developed the GMC strategy in its effort to develop practicable diagnostics tests with wide coverage of the genome," underlines Dr. Pierre Walrafen, project manager at Genomic Vision and co-inventor of the Genomic Morse Code.

"The modularity and evolutivity of the GMC will allow the constant adaptation of diagnostics tests to novel discoveries in the field of large rearrangements, which is barely beginning to reveal its extent and its importance in human health," he adds.

Eight patent families

The patent portfolio held by Genomic Vision in sole or joint ownership is continuously growing, with eight new patent families so far, covering technical developments as well as biomarkers and specific diagnostic tests involving large genome rearrangements.

"With active research in this growing field, a powerful tool which provides a unique vision and a network of key expert collaborators, Genomic Vision is uniquely positioned to improve on existing approaches and make new discoveries," says CEO, Aaron Bensimon. "New opportunities, e.g. in cross-licensing, will arise from the biomarker portfolio which will be a strong support in the growth of Genomic Vision as a global player in the field of molecular diagnostics."

More about molecular combing : http://www.genomicvision.com/technology-molecular-combing.php

More information about Genomic Vision : http://www.genomicvision.com

 


'/>"/>
SOURCE Genomic Vision
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
2. Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program
3. Genomic Health Presents Results From First Clinical Decision Making Study of Oncotype DX® Colon Cancer at the 2012 Gastrointestinal Cancers Symposium
4. Genomic Health Announces Year-End 2011 Financial Results, Provides 2012 Financial Outlook
5. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
6. Rubicon Genomics and Agendia Sign Agreement for Use of TransPLEX® Whole Genome RNA Amplification Technology With Symphony™ Cancer Diagnostics
7. Genomic Health and OncoMed Announce Strategic Alliance for Biomarker Research and Discovery Using Next Generation Sequencing
8. Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains
9. Discovered Evolution of Genomic Sequences -- from Ocean Archaea to Brain Cancer -- Leads to New Synthetic Replikin Vaccines for Infectious Diseases and Cancer
10. Rosetta Genomics Pays Off Secured Loan and Reclaims Unencumbered Rights to All Assets
11. Webinar Announcement: GenomeSpace: A New Solution for Integrating Genomic Analysis Tools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
Breaking Biology Technology:
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
Breaking Biology News(10 mins):